Search database
Filter
3084
Text search: medicines availability
Featured
Language
Document type
1705
540
416
163
148
37
31
27
6
5
5
1
Countries
146
126
109
85
82
80
70
68
67
67
66
60
58
57
56
48
47
47
45
41
41
41
31
27
27
27
25
22
21
21
19
18
17
17
17
15
15
14
14
14
14
12
12
12
9
9
9
8
8
8
7
7
6
6
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
480
183
106
103
89
68
57
56
52
22
21
19
17
17
16
16
16
16
16
15
15
14
14
14
12
12
12
11
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1337
278
203
132
62
46
42
2
1
1
Toolboxes
259
206
187
178
178
128
93
77
69
66
64
60
56
55
46
34
30
27
11
9
8
6
4
1
1
 Download
  View PDF
 Add to my MEDBOX

Pharmaceutical Services in Mozambique: foreign aid in public provision of medicines

Sachy, M; Almeida C; Pepe VLE (2018) CC
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function ... more
 Download
  View PDF
 Add to my MEDBOX

EPI 5: Anti-epileptic medicines for medication resistant convulsive epilepsy. [New 2015]

mhGAP; WHO (2015) C_WHO
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Medicines and Therapeutics Committee (MTCs) 04

Ministry of Health, Zambia (2017) C1
 Download
  View PDF
 Add to my MEDBOX

World Health Organization Model List of Essential Medicines 22st List
recommended

World Health Organization WHO (2021) C_WHO
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral ... more
 Download
  View PDF
 Add to my MEDBOX

Combined global demand forecasts for antiretroviral medicines and HIV diagnostic in low- and middle-income countries from 2015 to 2020

A. Adesina; J. Stover; M. Auton; et al. World Health Organization (2016) C_WHO
Technical Report AIDS Medicines and diagnostics service September 2016
 Download
  View PDF
 Add to my MEDBOX

Selection of essential medicines at country level

World Health Organization WHO (2020) C_WHO
Using the WHO model list of essential medicines to update a national essential medicines list Since 1977, WHO has been working with countries to design the package of essential ... more
 Add to my MEDBOX

Safety in administering medicines for neglected tropical diseases

World Health Organization WHO (2021) C_WHO
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive ... more
 Add to my MEDBOX

Guidelines on compounding of medicines

Pharmacy Board of Australia (2018) C1
 Add to my MEDBOX

WHO Good Governance for Medicines programme. an innovative approach to prevent corruption in the pharmaceutical sector

Baghdadi-Sabeti , G.; and F. Serhan World Health Organization WHO (2010) C_WHO
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
 Add to my MEDBOX

Libyan Essential Medicines List - 1st Edition

Government of Libya (2022) C1
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he ... more
 Add to my MEDBOX

Violence against women 60 years and older: Data availability, methodological issues, and recommendations for good practice

UN Women (2024) CC
This briefing note summarizes work undertaken by UN Women and WHO to inform the development of a module on violence against women 60 years and older that can be included in dedicated surveys on violence against women. It provides an overview of the challenges in the ... more
 Add to my MEDBOX

Standard Treatment Guidelines and Essential Medicines List for South Africa; Primary Healthcare Level 2020 Edition; Department of Health: Republic of South Africa

National Department of Health, South Africa National Department of Health, South Africa (2020) CC2
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Level II household survey to measure access to and use of medicines in Ghana

Daniel Kojo Arhinful Ministry of Health, Ghana (2011) C1
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of ... more
 Add to my MEDBOX

Joint request for selected preventive chemotherapy medicines and joint reporting form

World Health Organization WHO (2013) C_WHO
User Guide
 Download
  View PDF
 Add to my MEDBOX

Measuring medicine prices, availability, affordability and price components

World Health Organization; hai global (2008) C_WHO
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys ... more
 Add to my MEDBOX

The Pursuit of Responsible Use of Medicines

Sharing and Learning from Country Experiences (2012) C_WHO
 Download
  View PDF
 Add to my MEDBOX

The Interagency List of Essential Medicines for Reproductive Health

WHO (2006) C_WHO
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents the current international consensus on rational selection of essential reproductive health m ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems

World Health Organization WHO (2004) C_WHO
Guidelines
 Download
  View PDF
 Add to my MEDBOX

Provisional recommendations for blood services in light of the Zika virus epidemic: Potential impact on the spread of the infection and on the availability and safety of blood and blood components

Pan American Health Organization PAHO; World Health Organization, Regional Office for the Americas (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended

World Health Organization WHO (2011) C_WHO
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o ... more
 External Link
 Add to my MEDBOX

Health Care Financing in Ethiopia: Implications on Access to Essential Medicines

Eskender Eshetu Ali (2014) CC
Value in Health Regional Issues 4 C (2014) 37-40
 Download
  View PDF
 Add to my MEDBOX

India: Report of the Core-Committee for Revision of National List of Essential Medicines November 2015

Ministry of Health & Family Welfare (MOHFW), Government of India (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Tanzania: National Guidelines for Monitoring Medicines Safety

Tanzania Food & Drugs Authority (TFDA) (2010) C2
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
 Download
  View PDF
 Add to my MEDBOX

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Republic of Libera, Ministry for Health and Social Welfare (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus

World Health Organization WHO (2018) C_WHO
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I ... more
 Download
  View PDF
 Add to my MEDBOX

Standard Treatment Guidelines & National Essential Medicines List Tanzania Mainland

Ministry of Health, Community Development, Gender, Elderly and Children; Government of Tanzania (2018) C1
 External Link
 Add to my MEDBOX

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts

F. Bajunirwe; F. Tumwebaze; D.enis Akakimpa; et al. Hindawi; BioMed Research International (2018) C2
Research Article Hindawi BioMed Research International Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
 Download
  View PDF
 Add to my MEDBOX

WHO Regional Office for Europe advice on the use of experimental medicines for the treatment of COVID-19 patients

World Health Organization (Europe) (2020) C_WHO
9 April 2020 WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe ... more
 Add to my MEDBOX

Guidelines on management of blood and blood components as essential medicines

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Innovative delivery systems for paediatric medicines

World Health Organization WHO; Unitaid (2020) C_WHO
Technology landscape
 Download
  View PDF
 Add to my MEDBOX

WHO guidance on testing of “suspect” falsified medicines

World Health Organization WHO (2018) C_WHO
Annex 5, WHO Technical Report Series 1010, 2018
 External Link
 Add to my MEDBOX

Pharmacists' knowledge and perceptions about herbal medicines: A case study of Jos and environs

Jimann, N.S.; et al. (2017) CC
Med J DY Patil Univ 2017;10:229-33
 Download
  View PDF
 Add to my MEDBOX

Uganda National Communication Strategy for Promoting Rational Use of Medicines

Federal Ministry of Health, Uganda (2009) C1
 Download
  View PDF
 Add to my MEDBOX

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of ... more
 Download
  View PDF
 Add to my MEDBOX

Executive summary: the selection and use of essential medicines 2021

World Health Organization WHO (2021) C_WHO
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential ... more
 Download
  View PDF
 Add to my MEDBOX

Assessment of a revolving drug fund for essential asthma medicines in Benin

Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson, Chen-Yuan Chiang Journal of Pharmaceutical Policy and Practice (2015) C2
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7 Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed wh ... more
 External Link
 Add to my MEDBOX

WHO Global Atlas of Traditional, Complementary and Alternative Medicines. Text and map volume

Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (‎2005)‎. WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa World Health Organization WHO (2005) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Country perceptions for implementation of the new multi-drug resistant TB (MDR-TB) medicines.

F. Brigden; M. Ya Diul; R. H.Crespo, L. Ditiu, A. Kurats, etc al. Stop TB Partnership to reach; Medecins Sans Frontieres (2017) C1
Report: A survey conducted among the 27 high MDR-TB burden countries. March – July 2015 Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF). Accessed November 2017.
 Add to my MEDBOX

Standard treatment Guidelines & Essential Medicine List. National essential medicines list for Odisha

HEALTH & FAMILY WELFARE DEPARTMENT GOVERNMENT OF ODISHA (2014) C1
Accessed at 25.03.2014
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s ... more
 Add to my MEDBOX

Malawi: Assessment of the Logistics and Supply Chain Management of Anti-TB Medicines

Chana, R USAID (2009) C1
 Download
  View PDF
 Add to my MEDBOX

WHO implementation tool for monitoring the toxicity of new antiretroviral and antiviral medicines in HIV and viral hepatitis programmes

World Health Organization WHO (2018) C_WHO
 Add to my MEDBOX

Second-Line Antituberculosis Drugs in Children: A Commissioned Review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines

Malgosia Grzemska, Elizabeth Mathai World Health Organization WHO (2013)
 Download
  View PDF
 Add to my MEDBOX

A Guide to the Registration, Licensing and Scheduling of Medicinal Products in Malawi

Pharmacy, Medicines and Poisons Board, Malawi (2002) C2
First edition, November 1997 | Revised July 2002
 Download
  View PDF
 Add to my MEDBOX

South African National TB Guidelines - Children

Medicines Information Centre; SPES Bona; National HIV & TB Health Care Worker Hotline (2019) C2
Accessed: 08.10.2019 Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DISPENSING PREMISES (Malawi)

Pharmacy, Medicines & Poisons Board, Malawi (2015) C2
PMPB/INS-GUIDE/01
 Download
  View PDF
 Add to my MEDBOX

Zimbabwe National Pharmacovigilance Policy Handbook, 2nd ed.

Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care (2016) C2
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR GOOD CLINICAL TRIAL PRACTICE IN ZIMBABWE

Medicines Control Authority of Zimbabwe (MCAZ) (2012) C2
 External Link
 Add to my MEDBOX

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

European Medicines Agency EMA (2021) CC
7 April 2021
 Download
  View PDF
 Add to my MEDBOX

Swaziland: Guidelines on Import and Export Procedures for Medicines

Ministry of Health, Kingdom of Swaziland (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Zambia: GUIDELINES ON REGULATING THE CONDUCT OF CLINICAL TRIAL IN HUMAN PARTICIPANTS

Zambia Medicines Regulatory Authority (ZAMRA) (2016) C2
First Edition
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Moderna

European Medicines Agency EMA (2021) CC
 Download
  View PDF
 Add to my MEDBOX

Standards for Prosthetics and Orthotics Service Provision. 2015-2017 work plan

Department of Essential Medicines and Health Products (EMP) and NVI World Health Organisation (WHO); USAID; ISPO (2015) C_WHO
 External Link
 Add to my MEDBOX

Buruli Ulcer: a Review of the Current Knowledge

Yotsu,R.R.; K. Suzuki, R. E. Simmonds et al. Current Tropical Medicines Report (2018) CC
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim ... more
 Add to my MEDBOX

ECDC/EFSA/EMA second joint report on the integratedanalysis of the consumption of antimicrobial agents andoccurrence of antimicrobial resistance in bacteria fromhumans and food-producing animals

European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA) andEuropean Medicines Agency (EMA) (2017) C_CDC
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp ... more
 Download
  View PDF
 Add to my MEDBOX

Workplan Form

Ecumenical Pharmaceutical Network (EPN) (2011) C2
Annual procurement workplan for ordering medicines. Last revised 2015. Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Workplan_Form.doc
 Download
  View PDF
 Add to my MEDBOX

Regional Strategy on Regulation of Medical Products in the African Region, 2016–2025

World Health Organization, Regional Office for Africa (2016) C_WHO
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines ... more
 Download
  View PDF
 Add to my MEDBOX

Background Paper 6.11 Alzheimer Disease and other Dementias

B. Duthey, Ph.D; S. Tanna (2004) C2
20 February 2013 Update on 2004 Background Paper (Written by Saloni Tanna) Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
 Download
  View PDF
 Add to my MEDBOX

Rwanda Health Facility Assessment Core Questionnaire

USAID; Maternal and Child Survival Program (2014) CC
Service Availability and Readiness Assessment Tool
 Download
  View PDF
 Add to my MEDBOX

Medicine Prices in Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO), DFID, et al. (2006) C_WHO
Prices people pay for medicines.
 Download
  View PDF
 Add to my MEDBOX

Specifications and quantities for efficient procurement of essential equipment and laboratory commodities for HIV

Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al. World Health Organization (2015) C_WHO
Second Edition AIDS Medicines and diagnostics services July 2015
 External Link
 Add to my MEDBOX

Counterfeit drugs and medical devices in developing countries

Beverly D Glass (2014) CC
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f ... more
 Download
  View PDF
 Add to my MEDBOX

ແຜນຍຸດທະສາດ ວ່າດ້ວຍການຕ້ານຕໍ່ເຊື້ອຈຸລະຊີບທີ່ຕ້ານຕ່ໍຢາຕ້ານເຊື້ອ ຂອງ ສປປ ລາວ, 2019 - 2023

World Health Organization WHO (2019) C_WHO
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລ ... more
 Download
  View PDF
 Add to my MEDBOX

Strengthening the Health Systems Response to COVID-19 - Technical guidance #3

World Health Organization (Europe) (2020) C_WHO
Supply of essential medicines and health technologies (6 April 2020) This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on mea ... more
 Add to my MEDBOX

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and ... more
 Download
  View PDF
 Add to my MEDBOX

Standard treatment protocol for basic health services

Ministry of Health Nepal (2022) CC
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
 Download
  View PDF
 Add to my MEDBOX

Developing health centres and hospital s indices for Syria, based on HeRAMS dataset 2014

World Health Organization (2017) C_WHO
This research paper uses the Health Resources and services Availability Mapping System (HeRAMS) database to develop two composite indices – one for health centres and one for hospitals – in order to analyse and assess the health facilitie ... more
 Download
  View PDF
 Add to my MEDBOX

Kenya Pharmaceutical Sector Development Strategy

United Nations Industrial Develoopment Organization (2012) C1
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
 Download
  View PDF
 Add to my MEDBOX

The Interagency Emergency Health Kit 2017
recommended

World Health Organization WHO; UNICEF; ICRC; et al. (2019) C_WHO
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
 External Link
 Add to my MEDBOX

WHO Model Formulary for Children
recommended

World Health Organization WHO (2010) C_WHO
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009. In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Chil ... more
 Download
  View PDF
 Add to my MEDBOX

A model quality assurance system for procurement agencies

World Health Organization World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank (2007) C_WHO
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products ... more
 Add to my MEDBOX

WHO Guideline on Country Pharmaceutical Pricing Policies

World Health Organization WHO World Health Organization (2020) C_WHO
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov ... more
 Add to my MEDBOX

Pharmacological treatment of mental disorders in primary health care

World Health Organization WHO (2009) CC
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; an ... more
 Download
  View PDF
 Add to my MEDBOX

Modules on palliative care

WHO Collaborating Centre for community participation in palliative care and long term care (2013) C_WHO
Submission by the WHO Collaborating Centre on training and policy on opioid availability and WHO collaborating Centre for community participation in palliative care and long term care To the Indian Nursing Council for consideration to be included i ... more
 Download
  View PDF
 Add to my MEDBOX

Falling short

International Union Against Tuberculosis and Lung Disease; Treatment Action Group; msh; ec al. (2017)
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.
 Download
  View PDF
 Add to my MEDBOX

Updating national essential medicine lists: a step-by-step advocacy guide

MSH Management Sciences for Health (MSH) (2016) C1
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on cou ... more
 External Link
 Add to my MEDBOX

Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study

Rousham E. K., M. Aminul Islam, P. Nahar et al. (2018) C2
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibioti ... more
 Download
  View PDF
 Add to my MEDBOX

The Importance of Pharmacovigilance

World Health Organization WHO (2020) C_WHO
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic ... more
 Add to my MEDBOX

Diagnostics, medical devices & other health products catalog (GDF)

Stop TB Partnership World Health Organization WHO (2022) C_WHO
GDF is the largest global provider of quality-assured tuberculosis (TB) medicines, diagnostics, and laboratory supplies to the public sector. Since 2001, GDF has facilitated access to high-quality TB care in over 130 countries, providing treatmen ... more
 Add to my MEDBOX

Recommendations for Implementing Antimicrobial Stewardship Programs in Latin America and the Caribbean: Manual for Public Health Decision-Makers

Pan American Health Organization PAHO (2018) C2
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In ad ... more
 Download
  View PDF
 Add to my MEDBOX

Harmonized monitoring and evaluation indicators for procurement and supply management systems

WHO (2011) C_WHO
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
 Add to my MEDBOX

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu KIT (Royal Tropical Institute) Development Policy & Practice Vrije Universiteit Amsterdam (2008) CC
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
 Download
  View PDF
 Add to my MEDBOX

Medicine Information for Primary Care in Zimbabwe

Ministry of Health and Social Welfare, Zimbabwe (2012) C1
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a cruc ... more
 Download
  View PDF
 Add to my MEDBOX

2016 Health Facility Assessment for Reproductive Health Commodities and Services

The Republic of the Union of Myanmar, Ministry of Health and Sports, Department of Public Health, Department of Medical Services and UNFPA (2016) C1
A nationwide survey of a representative sample of health facilities across public health services in all states and regions of Myanmar has been undertaken since 2014 to track Reproductive Health Commodity Security (RHCS) indicators, such as the availabilit ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Diagnosis and Treatment of Malaria in Somalia

Federal Government of Somalia, Puntland & Somaliland, Zonal NMCPsMoH (2016) C1
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a ... more
 Add to my MEDBOX

WHO good manufacturing practices for pharmaceutical products: main principles

World Health Organization WHO (2014) C_WHO
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status, ... more
 Download
  View PDF
 Add to my MEDBOX

Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin

World Health Organization WHO (2021) C_WHO
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ... more
 Download
  View PDF
 Add to my MEDBOX

WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention

World Health Organization WHO (2022) C_WHO
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ... more
 External Link
 Add to my MEDBOX

United against Rabies Collaboration

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children ... more
 External Link
 Add to my MEDBOX

Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030: United Against Rabies Collaboration: first annual progress report

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are childre ... more
 Download
  View PDF
 Add to my MEDBOX

2014 Facility Assessment for Reproductive Health Commodities and Services

The Republic of the Union of Myanmar, Ministry of Health and Sports, Department of Medical Research, Department of Public Health, Department of Medical Care, UNFPA (2015) C1
A cross-sectional descriptive study design covering all states and regions was undertaken to:
1) To assess availability, utilization and supply chain management system for RH commodities at different levels of health facilities,
2) To ass ... more
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Guide for Implementing the Monitoring-Training-Planning (MTP) Approach to Build Skills for Pharmaceutical Management

Rational Pharmaceutical Management Plus Program Management Sciences for Health; USAID (2009) CC
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi ... more
 Download
  View PDF
 Add to my MEDBOX

Patents and licences on antiretrovirals: A snapshot

UNITAID; WHO (2014)
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV ... more
 Download
  View PDF
 Add to my MEDBOX

Using indicators to measure country pharmaceutical situations

WHO World Health Organization (WHO) (2006) C_WHO
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa ... more
 Download
  View PDF
 Add to my MEDBOX

Botswana: Guidelines for stability testing of pharmaceutical products

Ministry of Health, Gabarone, Botswana (2009) C2
This guideline is intended to provide requirements to applicants wishing to submit applications for registration of medicines in Botswana.
 Download
  View PDF
 Add to my MEDBOX

Uganda: THE NATIONAL DRUG POLICY AND AUTHORITY ACT

(1993) C2
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfact ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Pharmacovigilance and Medicine Information in Rwanda (2016)

Ministry of Health, Rwanda (2016) C2
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
 Download
  View PDF
 Add to my MEDBOX

Situation of Maternal and Newborn Health in Urban Slums of Bhubaneswar: Key Findings

Save the Children (2016) C2
Objectives of the Study: To understand the community needs, behaviors and perception for MNH in urban poor settings. To explore various factors (both demand and supply side) affecting care seeking for MNH. To assess the preparedness of the urban health system for providing MNH services at variou ... more